Jacob Van Naarden - Feb 10, 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & Pres., Lilly Oncology
Signature
/s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file
Stock symbol
LLY
Transactions as of
Feb 10, 2025
Transactions value $
$5,303,491
Form type
4
Date filed
2/12/2025, 04:28 PM
Previous filing
Feb 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Award $5.3M +6.1K +45.35% $868.88 19.6K Feb 10, 2025 Direct
holding LLY Common Stock 4.3K Feb 10, 2025 By spouse F1
holding LLY Common Stock 4.34K Feb 10, 2025 Van Naarden Family Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Award $0 +4.11K $0.00 4.11K Feb 10, 2025 Common Stock 4.11K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.